Whale liquidates ETH and HYPE long positions within three hours, reducing holdings by $18.8 million
According to ChainCatcher, monitored by HyperInsight, in the past three hours, the whale address starting with "0x88b" has closed a large number of ETH and HYPE long positions during the market pullback. In total, the address reduced 3,858 ETH long positions and 89,000 HYPE long positions, with the notional value of holdings decreasing by approximately $18.8 million. The weekly loss narrowed from $5.8 million to $1.9 million. The current total value of holdings at this address is about $55.6 million.
It is reported that this address once chased BTC longs at an average price of about $118,000 with 40x leverage, and the current floating loss on this position exceeds 252%, equivalent to about $2.48 million. Its SOL, HYPE, and ETH long positions were also trapped at high levels, and there is still a floating loss of $3.16 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
